Market Closed -
Nasdaq
01:30:00 16/05/2024 am IST
5-day change
1st Jan Change
1.57
USD
+0.64%
-12.29%
-80.47%
This article is reserved for members
Not a member ?
Free registration
Transcript : Helius Medical Technologies, Inc., Q1 2024 Earnings Call, May 13, 2024
14/05
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Posts Q1 Revenue $135,000
14/05
MT
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Posts Q1 Revenue $135,000, vs. Street Est of $0.1M
14/05
MT
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Tuesday as Traders Assess Earnings
07/05
MT
Top Premarket Decliners
07/05
MT
Helius Medical Technologies Prices $6.4 Million Public Offering
07/05
MT
Top Premarket Gainers
03/05
MT
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
24/04
CI
Top Premarket Gainers
03/04
MT
Helius Medical Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
29/03
CI
Transcript : Helius Medical Technologies, Inc., Q4 2023 Earnings Call, Mar 28, 2024
29/03
Helius Medical Technologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
29/03
CI
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Reports Q4 Revenue $134,000
29/03
MT
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
12/03
CI
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
04/03
CI
Traders Await Fresh Cues After Powell's Rate-Cut Commentary, Stifling US Equity Futures Pre-Bell
06/02
MT
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Earnings Flow Intensifies
06/02
MT
Top Premarket Gainers
06/02
MT
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
06/02
CI
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
11/01
CI
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Reports Q3 Revenue $143,000
10/11
MT
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Reports Q3 Revenue $143,000
10/11
MT
Helius Medical Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
10/11
CI
Transcript : Helius Medical Technologies, Inc., Q3 2023 Earnings Call, Nov 09, 2023
10/11
Helius Medical Technologies, Inc. Announces Impairment Charges for the Three Months Ended September 30 2023
10/11
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brainâs ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
More about the company
Last Close Price
1.57
USD
Average target price
5.7
USD
Spread / Average Target
+263.06%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**